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Persistent renal and extrarenal immune changes after severe
ischemic injury.
Background. Renal ischemia/reperfusion (I/R) injury is as-
sociated with delayed graft function and decreased long-term
allograft function. However, most experimental studies evaluat-
ing renal I/R injury have focused on acute events after ischemia.
T cells are potential candidates to link preservation injury, al-
loimmunity, and fibrosis. We hypothesized that severe renal I/R
injury would generate long-term kidney damage and immune
changes.
Methods. C57BL/6 mice underwent 60 minutes of warm
unilateral I/R injury or sham surgery and were studied for
6 weeks. Serum creatinine, renal histology, and albumin excre-
tion were measured. Phagocyte infiltration, CD4+ infiltration,
renal cytokine expression, and splenic lymphocyte intracellular
cytokine production were also measured in mice at 6 weeks.
Results. Serum creatinine levels rose following 60 minutes of
unilateral I/R injury compared to sham mice. Histologic analy-
sis of ischemic kidneys at 6 weeks revealed a pronounced loss
of tubular architecture and infiltration of inflammatory cells.
Phagocyte and CD4+ T-cell infiltration were significantly in-
creased in ischemic kidneys. This was accompanied by a sig-
nificant increase in interleukin (IL)-1b and regulated upon
activation, normal T-cell expressed and secreted (RANTES)
expression. Despite similar splenic CD4 and CD8 numbers,
intracellular cytokine staining of T cells revealed a significant
increase in interferon-gamma (IFN-c) in I/R injury mice com-
pared to sham mice.
Conclusion. Persistent renal and extrarenal immune re-
sponses occur after a single episode of severe I/R injury. These
immune processes resulting from injury could in turn have long-
term consequences on progression of renal disease in trans-
planted and native kidneys.
Ischemic acute renal failure (ARF) is associated with
decreased allograft survival in patients with transplanted
kidneys and high mortality in patients with native kidneys
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[1, 2]. Kidney transplants from living unrelated donors
[not well human leukocyte antigen (HLA)-matched] with
minimal ischemic injury have improved 3-year allograft
survival, compared with grafts from well-matched cadav-
eric donors with significant ischemia [3]. This implies that
renal ischemia/reperfusion (I/R) injury can have impor-
tant consequences on long-term graft survival.
Although much attention has focused on mechanisms
of early injury following an ischemic insult, the mecha-
nisms of long-term injury after severe ischemia are incom-
pletely understood. Most experimental work has focused
on the first 5 days following an ischemic insult. Renal
ischemic injury has been found to permanently damage
peritubular capillaries causing hypoxia, which may be in-
volved in the progression of chronic renal disease after
ARF [4, 5]. Tubulointerstitial influx of inflammatory cells
is found in many forms of chronic renal diseases, includ-
ing “nonimmune” diseases such as diabetes and hyper-
tension [6]. Thus, immune changes after “nonimmune”
injury may participate in progressive dysfunction.
It has recently been demonstrated that the T cell,
specifically the CD4+ T cell is an important modulator of
renal I/R injury [7, 8]. Given that a single episode of renal
I/R injury is associated with increased chronic rejection
(chronic allograft nephropathy) [1], we hypothesized that
long-term inflammatory changes, particularly in CD4 T
cells, would occur. In this study we investigated late im-
munologic changes after severe renal I/R injury in the
mouse (60 minutes I/R injury—to simulate severe injury
which has long term clinical consequences; unilateral to
allow mouse survival). We found that at 6 weeks after
severe I/R injury there was a loss of tubular architecture
and this is accompanied by an increase in phagocyte and
CD4+ infiltration, as well as up-regulation of interleukin
(IL)-1 and regulated upon activation, normal T-cell ex-
pressed and secreted (RANTES). When we investigated
extrarenal changes in T cells, we unexpectedly found
that spleens from ischemic mice, but not sham-operated
mice, had significant increases in T-cell interferon-gamma
(IFN-c) production, despite similar numbers of CD4 and
CD8 cells. Thus, a single ischemic episode to the kidney
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Male C57BL/6J, 5 to 7 weeks of age from Jackson Lab-
oratories (Bar Harbor, ME, USA) underwent 60 min-
utes unilateral ischemia or sham surgery and were then
monitored for 6 weeks postischemia. Briefly, 25 to 35 g
mice were anesthetized with intraperitoneal pentobarbi-
tal (75 mg/kg), underwent abdominal incisions, and had
their right renal pedicle bluntly dissected. A microvas-
cular clamp was placed on the right renal pedicle for
60 minutes while the animal was kept at a constant tem-
perature (∼37◦C) and well hydrated. After 60 minutes,
the clamp was removed, wounds sutured, and the ani-
mal was allowed to recover. Animals were monitored
and maintained for 6 weeks before sacrifice. Sham an-
imals underwent the same surgical procedure without
clamping of the renal artery. Since we were interested
in examining long-term responses postischemia, we used
a severe model of renal I/R injury. Sixty minutes of is-
chemia was chosen because it produces severe damage
to the kidney and was therefore more likely to initiate
an immune response. Mild episodes of ischemia to either
transplant or native kidneys are not thought to result in
significant long-term changes. The unilateral model was
chosen to prevent mortality in mice, since they do not
survive 60 minutes of bilateral renal ischemia for more
than 2 days (data not shown).
Assessment of renal function
Blood samples were obtained from mice at various
time points, and serum creatinine levels were measured
as markers of renal function. Serum creatinine was an-
alyzed on blood samples using a 557A Creatinine Kit
(Sigma Diagnostics, St. Louis, MO, USA) and analyzed
on a Cobas Mira S Plus automated analyzer (Roche Di-
agnostics Corp., Indianapolis, IN, USA).
Urinary albumin clearance
Albuminuria is a key indicator of progressive renal dis-
ease [9] and therefore we collected urine for analysis
of albumin excretion in I/R injury compared to sham-
operated mice. Urine volumes and albumin were ana-
lyzed in mice at 0, 3, and 6 weeks postischemia. Mice
were placed in specially designed murine metabolic cages
for a 24-hour period. Urine collected during this period
was analyzed for albumin using an enzyme-linked im-
munosorbent assay (ELISA) kit (Bethyl Laboratories,
Montgomery, TX, USA) per manufacturer’s instructions.
Albumin clearance was determined using albumin con-
centration and urine creatinine.
Assessment of histologic injury
Kidneys were taken at 6 weeks postischemia and an-
alyzed by hematoxylin and eosin staining. Ischemic kid-
neys were compared to contralateral and sham-operated
kidneys by two blinded reviewers.
Myeloperoxidase (MPO) assay to quantify phagocytes
An MPO assay was performed to quantify neutrophils
in postischemic murine kidney tissue, as previously de-
scribed in depth [10]. Kidney samples were homogenized
(1:20 wt/vol) in ice-cold KPO4 buffer. Samples were spun
at 17,000g for 30 minutes at 4◦C, and pellets were washed
and spun an additional two times. Then 0.5% hexade-
cyltrimethylammonium bromide-10 mmol/L EDTA in
KPO4 buffer was added to the remaining pellet (6:1).
Suspensions were freeze/thawed three times and then in-
cubated for 20 minutes at 4◦C. Following final centrifu-
gation, supernatants were measured for MPO. Changes
in absorbance over 3.5 minutes were recorded at 460 nm.
One unit of MPO activity was defined as a change of ab-
sorbance of 1 per minute. Results were expressed as units
MPO per mg of protein, which was determined using the
bicinchoninic acid assay (Pierce Chemical Co., Rockford,
IL, USA).
CD4+ and neutrophil detection
by immunohistochemistry
Tissue sections were prepared as described above for
routine histology. Sections (4 lm) were prepared on a
cryostat and mounted on Fisher Superfrost Plus slides,
fixed in ice-cold acetone for 1 to 2 minutes, and allowed
to air dry. Sections were then blocked with 1:100 nor-
mal rabbit serum in phosphate-buffered saline (PBS)
containing Vector Avidin DH (Vector Laboratories, Inc.,
Burlingame, CA, USA). The following primary antibod-
ies were then added to the sections: GK 1.5 (rat antimouse
CD4) (American Type Culture Collection, Manassas,
VA, USA) and 7/4 (rat antimouse neutrophil) (Accurate
Chemical & Scientific Corp., Westbury, NY, USA). Sec-
tions were then incubated for 1 hour at room tempera-
ture. An isotype control primary antibody was used as a
background staining control. Sections were then rinsed
in PBS and treated with 3% hydrogen peroxide in bi-
otin (10 lg/L PBS) to block the biotin-binding sites. Af-
ter three washes in PBS, the slides were incubated with
a biotin-conjugated rabbit antirat IgG secondary anti-
body (Vector Laboratories Inc.) for 35 minutes at room
temperature. Sections were once again washed, and were
then incubated for 45 minutes in Vector Elite ABC (Vec-
tor Laboratories Inc.). Sections were washed and de-
veloped with 3-amino-9-ethyl-carbazole, counterstained
with hematoxylin, and mounted using Glycergel (Dako
Corp., Carpinteria, CA, USA). After the entire kidney
section was viewed, ten high-powered (×40) fields were
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counted in the area of the corticomedullary junction, and
number of cells per high powered field was quantified in
a blinded fashion.
CD4+ and CD8+ splenic populations by flow cytometry
Spleens were collected from euthanized mice, homog-
enized, and treated with ammonium chloride to remove
red blood cells. Washed cells were filtered through a 70 lm
nylon cell strainer and counted in a hemocytometer. One
million cells were treated with Fc Block for 30 minutes
then stained with anti-CD8 fluorescein isothiocyanate
(FITC) and anti-CD4 phycoerythrin (Pe) (Pharmingen,
San Diego, CA, USA) for 1 hour on ice. Cells were then
washed twice, then resuspended in 1% formaldehyde.
Flow cytometry was performed using an Epics II (Coul-
ter, Hialeah, FL, USA) gating on appropriate unstained
and isotype controls.
Bioplex Protein Array System
A panel of cytokines was measured in kidney samples
taken at 6 weeks postischemia. Ischemic, contralateral
kidneys and sham kidneys were measured in duplicate
using the Bioplex Protein Array System (Bio-Rad, Her-
cules, CA, USA), according to the instructions of the
manufacturer. This is a novel multiplexed, particle based,
flow cytometric assay which utilizes anticytokine mono-
clonal antibodies linked to microspheres incorporating
distinct proportions of two fluorescent dyes [11]. The as-
say enables quantification of several mediators in a sam-
ple volume as small as 15 lL. Our assay was customized
to detect and quantify IL-1b , IL-2, IL-4, IL-6, IFN-c, tu-
mor necrosis factor-a (TNF-a), and RANTES. For each
cytokine, eight standards ranging from 2 to 3200 pg/mL
and the minimal detectable dose was <10 pg/mL.
Intracellular cytokine staining
Spleens were collected from animals at 6 weeks
postischemia and a lymphocyte-rich cell suspension was
obtained using Lympholyte M cell separation media.
Anticytokine antibodies were used in conjunction with
antibodies against cell surface antigens for the purpose
of studying specific lymphocyte populations. Cells were
surfaced stained with CD3. Intracellular staining was per-
formed using a fluorescent-conjugated anti-IFN-c anti-
body and anti-IL-4 antibody. The final suspension was
analyzed on a FACS flow cytometer. Appropriate unstim-
ulated and isotype controls were also used.
Statistical analysis
Data was expressed as mean ± SE. Analysis of vari-
ance (ANOVA) and Fisher least-significant difference
test were used to compare means of multiple groups sta-
tistically. For paired data, Student t test was used. Statis-

























Fig. 1. Postischemic renal function in mice following 60 minutes unilat-
eral ischemia (◦) compared to sham-operated animals (•) as measured






























Fig. 2. Urinary albumin clearance at 0, 3, and 6 weeks postischemia
in ischemic mice () compared to sham-operated mice (), determined
using a mouse albumin enzyme-linked immunosorbent assay (ELISA)
and measurement of urine creatinine. Results are expressed as % of




Serum creatinines were followed in I/R injury versus
sham-operated mice over 6 weeks. Early injury to the kid-
ney was characterized by a significant increase in serum
creatinine at 24, 48, and 72 hours in I/R injury mice com-
pared to sham-operated mice. The increase in creatinine
reflects the net function of both kidneys (Fig. 1). Albu-
min clearance was measured in I/R injury versus sham-
operated mice at 0, 3, and 6 weeks following I/R injury
(Fig. 2). At 3 and 6 weeks postischemia there is a sig-
nificant increase in albumin clearance in I/R injury mice
compared to sham-operated mice (P < 0.05).
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Fig. 3. Histologic analysis of kidney tissue 6 weeks postischemia using hematoxylin and eosin staining. Gross structural changes are observed
between contralateral kidneys (A, left) and ischemic kidneys (A, right). Morphologically ischemic kidneys (B) show a loss of tubular architecture,
tubular destruction, and cyst formation. Contralateral (C) and sham-operated kidneys (D) show normal histology (representative of N = 12).
Structural characterization of long-term injury
Six weeks following a severe ischemic insult to the kid-
ney, the ischemic kidney is shrunken in size to approxi-
mately half that of the contralateral kidney (Fig. 3A). His-
tologically, kidney sections of ischemic kidneys displayed
a loss of tubular architecture with dilation of tubules and
cyst formation (Fig. 3B). Contralateral kidneys and kid-
neys obtained from sham-operated mice (Fig. 3C and D,
respectively) show normal histology.
Long-term phagocyte infiltration
Kidneys were analyzed for phagocyte infiltration
6 weeks postischemia (Fig. 4). An MPO assay which de-
tects neutrophils, but may also detect macrophage infil-
tration, was used [10]. Long-term I/R injury kidneys had
a significant increase in MPO levels compared to both
contralateral kidneys and kidneys obtained from sham-
operated animals. We also performed immunostaining of
neutrophils and a similar increase was found in kidney
sections from ischemic mice compared to contralateral




















Fig. 4. Phagocyte infiltration as measured by myeloperoxidase (MPO)
in sham (), ischemic () and contralateral kidneys () 6 weeks postis-
chemia (N = 4 per group). IRI is ischemia/reperfusion injury.
CD4+ T-cell infiltration
T-cell infiltration into the kidney 6 weeks postis-
chemia was analyzed. Figure 6 shows representative




























Fig. 5. Neutrophil infiltration as measured by immunohistochemistry
in sham (), ischemic () and contratateral kidneys () 6 weeks postis-
chemia (N = 4 per group). IRI is ischemia/reperfusion injury.
pictomicrographs of kidney sections stained with a
specific antibody to CD4+. Sham-operated animals
(Fig. 6A) and contralateral kidneys (Fig. 6B) show base-
line levels of CD4+ T cells. In contrast, the I/R injury
kidney (Fig. 6C) shows a massive influx of CD4+ T cells.
We further quantified infiltrating CD4+ T cells and num-
bers are represented in Figure 7. Ischemic kidneys have
a significant increase in numbers of CD4+ T cells at 6
weeks postischemia.
Long-term renal cytokine changes
We analyzed a panel of cytokine expression in kid-
neys at 6 weeks postischemia using a cytokine protein
array system. We found a significant difference in IL-1b
and RANTES expression in ischemic kidneys versus con-
tralateral and sham kidneys (Fig. 8). However, no differ-
ences were found in IL-2, IL-4, IL-6, IFN-c, and TNF-a.
Systemic immune changes in lymphoid organs
We hypothesized that long-term extrarenal changes in
T cells could occur after an episode of renal I/R injury, and
we therefore examined distant lymphoid tissue. Splenic
cells were analyzed for CD4+/CD8+ positive cells. FACS
analysis showed similar numbers of CD4+/CD8+ cells in
spleens obtained from I/R injury and sham-operated mice
(Fig. 9). Given that T-cell IFN-c production has been asso-
ciated with early renal I/R injury [8, 12], we hypothesized
that a long-term phenotypic shift of T cells to produce
IFN-c could occur. Intracellular cytokine staining was
performed and Figure 10 shows that splenic T cells from
I/R injury mice have an increased production of IFN-c
at 6 weeks postischemia compared to sham animals. We
also analyzed splenic IL-4 cytokine production, however,
found no differences between ischemic and sham animals
(data not shown).
DISCUSSION
In this study, we demonstrate that a single episode of
severe warm ischemic injury to the kidney is associated
with significant long-term kidney inflammation, partic-
ularly CD4+ infiltration and, unexpectedly, distant im-
mune cell changes. Although the inflammatory pathways
involved in renal I/R injury have been extensively evalu-
ated to focus on short-term outcomes, there has been little
attention on long-term inflammatory changes after single
kidney ischemic injury. Many studies have implicated se-
vere I/R injury as an antigen-independent risk factor for
late renal allograft failure [13–15]. With organ shortages
for transplantation, more nonheart-beating cadavers as
well as brain-dead cadavers with long ischemic times are
being used for organ donation. Despite lifelong immuno-
suppression of recipients, immunologic responses remain
the leading factor in the pathogenesis of chronic rejection.
Other nonalloreactive factors such as cold ischemia have
been investigated and have also been found to contribute
to late damage [16].
We used a model of severe ischemia in order to learn
about the long-term effects of ischemia since in the kid-
ney transplant patients long ischemic times lead to worse
long-term outcomes [17]. Shorter degrees of ischemia are
clinically less established to be associated with signifi-
cant long-term problems. We found a prominent change
in gross and microscopic renal structure in the clamped
kidney 6 weeks after ischemia. It is quite likely that the
ischemic kidney did not recover from injury. The I/R in-
jury kidney had shrunk to approximately half the size of
the contralateral kidney. The I/R injury kidney also de-
veloped cystic changes, tubular dropout, and interstitial
fibrosis. These are the hallmarks of end-stage kidneys [6].
The presence of albumin in urine is a marker of loss of
renal barrier function to plasma proteins, and a marker
of progressive kidney disease in both allograft and na-
tive kidney. There was a significant rise in urine albu-
min clearance over time in I/R injury mice compared to
sham-operated mice, which suggest glomerular dysfunc-
tion and/or abnormalities in tubular uptake of albumin.
Given that albumin clearance is significantly increased in
ischemic mice by 3 weeks, the injured kidney is the most
likely source rather than hyperfiltration injury to the con-
tralateral kidney.
In conjunction with the gross structural and histologic
changes, we observed a large influx of leukocytes into
I/R injury kidneys. There was an increase in MPO levels,
reflecting an increase in neutrophils and macrophages.
This was confirmed using specific immunostaining for
neutrophils which showed a significant increase in neu-
trophil infiltration into the ischemic kidney. Based on the
functional role for CD4+ T cells in early I/R injury, au-
toimmunity, and allograft rejection, we specifically exam-
ined these cells in I/R injury kidney. Unlike the paucity
of CD4+ cells within a few days after I/R injury [8], there
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Fig. 6. CD4+ infiltration as measured using specific CD4 antibodies at 6 weeks in sham kidneys (A), contralateral kidneys (B), and ischemic
kidneys (C).
was a marked infiltration of CD4+ T cells throughout
the I/R injury kidney, but not in the sham or normal kid-
ney. Inflammatory infiltrates characterize progressive re-
nal disease in both human allografts and native kidneys,
and are putative mediators of the progressive fibrosis that
ultimately leads to a loss of function [6]. This study is
the first demonstration of marked CD4+ infiltration late
after I/R injury, and may facilitate rejection as well as
progression of renal disease.
In conjunction with an increase in infiltrating CD4 T
cells was an increase in IL-1b and RANTES. Previous
in vitro studies have shown that proinflammatory cy-
tokines such as IL-1b can induce RANTES production
by renal tubular epithelial cells. Activation of comple-
ment of endothelial cells also contributes to production
of chemokines [18]. Cytokines and chemokines released
by damaged or activated renal resident cells can direct T-
cell infiltration [16]. A recent study has also demonstrated
that T cells once recruited can, in turn, promote further
chemokine production through combined cognate and
soluble factor-mediated interactions with resident tubu-
lar epithelial cells [19]. Recently, T-cell activation has
been demonstrated to occur totally independently of anti-
gen and RANTES has been shown to directly activate T
cells [20]. RANTES up-regulation has been shown to oc-
cur in renal I/R injury, so this is one possible mechanism
for T-cell activation in the absence of alloantigen [21].
With the marked CD4+ T-cell infiltration in the I/R in-
jury kidney, we postulated that extrarenal lymphoid or-
gans could also undergo changes in immune cells. We
examined CD4 and CD8 T-cell counts in spleens of I/R
injury and sham-operated animals and found the num-
bers to be similar in both groups. Given that qualita-
tive changes in T cells may be occurring and that IFN-c
production by T cells has been implicated to be pivotal




























Fig. 7. CD4+ infiltration quantification in sham (), ischemic () and
contratateral kidneys () 6 weeks postischemia (N = 4 per group). IRI
is ischemia/reperfusion injury.
change in T cells occurred in spleen. Using intracellular
cytokine staining, a significant increase in T-cell IFN-c
was observed in I/R injury mice compared to sham-
operated mice. IFN-c has been previously shown to be
up-regulated in kidney following renal I/R injury [21]. It
is also well known to enhance expression of major his-
tocompatibility complex (MHC) class I and II antigens
which are likely to predispose ischemic damaged kidneys
to the development of graft rejection [22, 23]. In a human
study, it has been recently shown that IFN-c may have an
influence on acute rejection of kidney transplants, partic-
ularly those patients on cyclosporine therapy [24]. IFN-c
was also associated with worse long-term graft function
[24]. IFN-c has also recently been shown to mediate Toll-
like receptor 4 mRNA expression following renal I/R in-
jury [25]. We speculate that the increase in T-cell IFN-c in
I/R injury animals could play a role in progressive renal
injury and susceptibility to alloimmune responses.










































Fig. 8. Interleukin (IL)-1b and regulated upon activation, normal T-
cell expressed and secreted (RANTES) are significantly up-regulated at
6 weeks postischemia in ischemic kidneys compared to sham, contralat-
eral, and normal kidneys (N = 5 per group). IRI is ischemia/reperfusion
injury.
Our study was limited by the need of keeping a “nor-
mal” kidney in the I/R injury mouse due to inability to
dialyze the mice for kidney failure as is performed in hu-
mans. The remnant healthy kidney could play a role in the
outcomes of the injured kidney. We also recognized that
splenic lymphocytes may not be representative of all lym-
phocytes. Although they may not represent the systemic
circulation as a whole, they do represent a large number
of immune cells. Furthermore, we used a model of severe
injury in order to accentuate the possible injury as well
as immune response. In milder injury, as we and others
have previously shown in studies conducted in rats and
humans, changes to kidney function and structure are less
clinically pertinent. It is also important to note that some
of these long-term changes may occur earlier (as in after
2 weeks of injury); however, even if changes occur earlier
after injury, it is important to point out that these changes
persist and are still present at 6 weeks postischemia. We



















Fig. 9. Splenic CD4+ and CD8+ cell numbers at 6 weeks postischemia





















Fig. 10. Splenic T-cell interferon-gamma (IFN-c) production mea-
sured by intracellular cytokine staining 6 weeks postischemia in
sham-operated mice () and ischemic mice () (N = 8). IRI is is-
chemia/reperfusion injury.
rats, and found that the marked kidney fibrosis, mononu-
clear cell infiltrate, and cyst formation are not present;
however, some CD4 infiltration was seen [26].
Based on these novel findings of long-term intra- and
extrarenal changes in T cells in this new experimen-
tal model, future studies will examine the mechanisms
and consequences of the long-term inflammatory changes
postisichemia. Among the key questions is if inflamma-
tory changes mediated by immune cells directly con-
tribute to a progressive decline in kidney injury or if
the inflammatory changes mediated by immune cells
are merely a secondary phenomenon and response to
injury.
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